Updated: 24 Jun 2009
Short-term treatment of anxiety that is severe or disabling occurring alone or with insomnia.
Intermediate-acting benzodiazepines (anxiolytics).
1.5mg yellow tablets; 3 mg pink tablets. Both hexagonal scored tablets marked with L and tablet strength.
Tablets, bromazepam 1.5 mg , 3mg . Lexotan is not prescribable on the NHS.
3 - 18 mg daily in divided doses.
1.5 - 9 mg daily in divided doses.
Chronic pulmonary insufficiency, chronic renal or hepatic disease. The elderly. Judgement and dexterity may be impaired, patients should be warned of these effects.
Do not use alone to treat depression or anxiety associated with depression. In cases of bereavement, psychological adjustment may be impaired. Avoid long-term use; withdraw gradually.
Drowsiness, light-headedness, muscle weakness, ataxia, confusion, vertigo, GI upset, skin rashes, impaired alertness and dexterity. Urinary retention, changes in libido.
Rarely blood disorders and jaundice. Abnormal psychological reactions, Risk of dependence increases the higher the dose and the longer the treatment.
Acute pulmonary insufficiency, respiratory depression, phobic or obsessional states, chronic psychosis, myasthenia gravis. Pregnancy, labour and lactation.